Related Experiment Video
Updated: Mar 22, 2026

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Sphingosine-1-Phosphate Signaling in Endothelial Disorders
1Department of Pathology and Laboratory Medicine, Center for Vascular Biology, Weill Cornell Medical College, 1300 York Ave, Room A607B/Box 69, New York, NY, 10065, USA. tes2015@med.cornell.edu.
Sphingosine-1-phosphate (S1P) shows promise in restoring endothelial function, offering potential therapies for vascular and microvascular diseases. Targeting S1P receptors (S1PR) may bridge the gap between vascular biology research and clinical practice.
Area of Science:
- Vascular Biology
- Endothelial Function
- Pharmacology
Background:
- Sustained endothelial activation contributes to tissue edema, inflammation, and organ failure.
- Current therapies do not specifically target endothelial function restoration.
- Sphingosine-1-phosphate (S1P) is a key modulator of endothelial responses.
Purpose of the Study:
- To review the role of S1P and its receptors (S1PR) in endothelial function.
- To discuss the therapeutic potential of targeting S1PR in arterial and microvascular diseases.
- To explore bridging the gap between vascular research and clinical application.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of S1P and S1PR involvement in endothelial health and disease.
- Discussion of therapeutic strategies targeting S1PR.
Main Results:
- S1P modulates endothelial function and responses to injury.
- S1PR are identified as potential therapeutic targets for various vascular conditions.
- Targeting S1PR offers promise for treating both arterial and microvascular dysfunction.
Conclusions:
- S1P and S1PR play critical roles in endothelial function and vascular injury.
- Targeting S1PR presents a viable therapeutic strategy for endothelial dysfunction.
- This approach could significantly advance clinical practice in vascular medicine.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
IP3/DAG Signaling Pathway
Paracrine Signaling
Amplifying Signals via Enzymatic Cascade
Peripheral Artery Disease I: Introduction
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...

